Adherence to extended release tolterodine versus immediate- and extended-release oxybutynin among commercially-insured patients with overactive bladder

被引：0

作者：

Ollendorf, DA

Jumadilova, Z

Varadharajan, S

Girase, P

机构：

[1] Pharmetrics, Watertown, MA USA

[2] Pfizer Inc, New York, NY USA

来源：

VALUE IN HEALTH | 2005年 / 8卷 / 03期

关键词：

D O I：

10.1016/S1098-3015(10)63137-3

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

引用

页码：416 / 416

页数：1

共 50 条

[21] Reduced perception of urgency in treatment of overactive bladder with extended-release tolterodine
Freeman, R
Hill, S
Millard, R
Slack, M
Sutherst, J
OBSTETRICS AND GYNECOLOGY, 2003, 102 (03): : 605 - 611
[22] Oxybutynin extended-release - A review of its use in the management of overactive bladder
Siddiqui, MAA
Perry, CM
Scott, LJ
DRUGS, 2004, 64 (08) : 885 - 912
[23] Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial - Comment
Wein, AJ
BJU INTERNATIONAL, 2003, 92 (07) : 747 - 747
[24] An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder
Goldenberg, MM
CLINICAL THERAPEUTICS, 1999, 21 (04) : 634 - 642
[25] Oxybutynin extended release and tolterodine immediate release - A health economic comparison
Getsios, D
Caro, JJ
Ishak, KJ
El-Hadi, W
Payne, K
O'Connel, M
Albrecht, D
Feng, W
Dubois, D
CLINICAL DRUG INVESTIGATION, 2004, 24 (02) : 81 - 88
[26] The clinical efficacy of tolterodine extended-release is maintained for 24 h in patients with overactive bladder
Dmochowski, Roger
Kreder, Karl
MacDiarmid, Scott
Carlsson, Martin
Guan, Zhonghong
BJU INTERNATIONAL, 2007, 100 (01) : 107 - 110
[27] Onset of efficacy of tolterodine extended release in patients with overactive bladder
Sussman, David O.
Kraus, Stephen R.
Carlsson, Martin
Guan, Zhonghong
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (04) : 777 - 781
[28] Immediate- and extended-release ciprofloxacin similar for UTI
不详
BJU INTERNATIONAL, 2009, 104 : 9 - 9
[29] Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial
Y. Homma
K. Kawabe
World Journal of Urology, 2004, 22 : 251 - 256
[30] Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial
Homma, Y
Kawabe, K
WORLD JOURNAL OF UROLOGY, 2004, 22 (04) : 251 - 256

← 1 2 3 4 5 →